Toxicological assessment of nanoparticle interactions with the pulmonary system

References

• Abdolahpur Monikh, F., A. Praetorius, A. Schmid, P. Kozin, B. Meisterjahn, E. Makarova, T. Hofmann, and F. Von Der Kammer. 2018. “Scientific Rationale for the Development of an OECD Test Guideline on Engineered Nanomaterial Stability.” NanoImpact 11: 42–50. doi:10.1016/j.impact.2018.01.003.
   Web of Science ®Google Scholar
• Accomasso, L., C. Cristallini, and C. Giachino. 2018. “Risk Assessment and Risk Minimization in Nanomedicine: A Need for Predictive, Alternative, and 3Rs Strategies.” Front Pharmacol 9: 228.
   PubMed Web of Science ®Google Scholar
• Accomasso, L., C. Gallina, V. Turinetto, and C. Giachino. 2016. “Stem Cell Tracking with Nanoparticles for Regenerative Medicine Purposes: An Overview.” Stem Cells International 2016: 7920358. doi:10.1155/2016/7920358.
   PubMedGoogle Scholar
• Aderem, A., and D.M. Underhill. 1999. “Mechanisms of Phagocytosis in macrophages.” Annual Review of Immunology 17: 593–623. doi:10.1146/annurev.immunol.17.1.593.
   PubMed Web of Science ®Google Scholar
• Al-Hallak, M. H., M. K. Sarfraz, S. Azarmi, W. H. Roa, W. H. Finlay, C. Rouleau, and R. Lobenberg. 2012. “Distribution of Effervescent Inhalable Nanoparticles after Pulmonary Delivery: An in Vivo Study.” Therapeutic Delivery 3(6): 725–734. doi:10.4155/tde.12.42.
   PubMedGoogle Scholar
• Alfagih, I., N. Kunda, F. Alanazi, S. R. Dennison, S. Somavarapu, G. A. Hutcheon, and I. Y. Saleem. 2015. “Pulmonary Delivery of Proteins Using Nanocomposite Microcarriers.” Journal of Pharmaceutical Sciences 104(12): 4386–4398. doi:10.1002/jps.24681.
   PubMed Web of Science ®Google Scholar
• Ânia, M., R. Emilio, M. Angel, G. Rafael, and F. Manuel. 2018. “Protein Interactions and Nanomaterials: A Key Role of the Protein Corona in Nanobiocompatibility.” Protein-Protein Interaction Assays, Mahmood-ur-Rahman Ansari, IntechOpen. doi:10.5772/intechopen.75501.
   Google Scholar
• Anttila, S., J. Hukkanen, J. Hakkola, T. Stjernvall, P. Beaune, R. J. Edwards, A. R. Boobis, O. Pelkonen, and H. Raunio. 1997. “Expression and Localization of CYP3A4 and CYP3A5 in Human Lung.” American Journal of Respiratory Cell and Molecular Biology 16(3): 242–249. doi:10.1165/ajrcmb.16.3.9070608.
   PubMed Web of Science ®Google Scholar
• Arvizo, R. R., O. R. Miranda, M. A. Thompson, C. M. Pabelick, R. Bhattacharya, J. D. Robertson, V. M. Rotello, Y. S. Prakash, and P. Mukherjee. 2010. “Effect of Nanoparticle Surface Charge at the Plasma Membrane and beyond.” Nano Letters 10(7): 2543–2548. doi:10.1021/nl101140t.
   PubMed Web of Science ®Google Scholar
• Azarmi, S., R. Löbenberg, W. H. Roa, S. Tai, and W. Finlay. 2008. “Formulation and in Vivo Evaluation of Effervescent Inhalable Carrier Particles for Pulmonary Delivery of Nanoparticles.” Drug Development and Industrial Pharmacy 34(9): 943–947. doi:10.1080/03639040802149079.
   PubMed Web of Science ®Google Scholar
• Babincova, M. and P. Babinec. 2006. “Aerosolized VEGF in combination with intravenous magnetically targeted delivery of DNA–nanoparticle complex may increase efficiency of cystic fibrosis gene therapy.” Medical Hypotheses 67(4): 1002.
   PubMed Web of Science ®Google Scholar
• Bachler, G., S. Losert, Y. Umehara, N. Von Goetz, L. Rodriguez-Lorenzo, A. Petri-Fink, B. Rothen-Rutishauser, and K. Hungerbuehler. 2015. “Translocation of Gold Nanoparticles across the Lung Epithelial Tissue Barrier: Combining in Vitro and in Silico Methods to Substitute in Vivo Experiments.” Particle and Fibre Toxicology 12(1): 18. doi:10.1186/s12989-015-0090-8.
   PubMedGoogle Scholar
• Bakand, S., and A. Hayes. 2016. “Toxicological Considerations, Toxicity Assessment, and Risk Management of Inhaled Nanoparticles.” International Journal of Molecular Science 17(6): 929.
   Web of Science ®Google Scholar
• Bakand, S., A. Hayes, and F. Dechsakulthorn. 2012. “Nanoparticles: A Review of Particle Toxicology following Inhalation Exposure.” Inhalation Toxicology 24(2): 125–135. doi:10.3109/08958378.2010.642021.
   PubMed Web of Science ®Google Scholar
• Basei, G., D. Hristozov, L. Lamon, A. Zabeo, N. Jeliazkova, G. Tsiliki, A. Marcomini, and A. Torsello. 2019. “Making Use of Available and Emerging Data to Predict the Hazards of Engineered Nanomaterials by Means of in Silico Tools: A Critical Review.” NanoImpact 13: 76–99. doi:10.1016/j.impact.2019.01.003.
   Web of Science ®Google Scholar
• Bello, D., and D. B. Warheit. 2017. “Biokinetics of Engineered nano-TiO2 in Rats Administered by Different Exposure Routes: Implications for Human Health.” Nanotoxicology 11(4): 431–433. doi:10.1080/17435390.2017.1330436.
   PubMed Web of Science ®Google Scholar
• Berlinski, A. 2015. “Assessing New Technologies in Aerosol Medicine: Strengths and Limitations.” Respiratory Care 60(6): 833–847. doi:10.4187/respcare.03551.
   PubMed Web of Science ®Google Scholar
• Bhattacharjee, S., L.H. De Haan, N.M. Evers, X. Jiang, A.T. Marcelis, H. Zuilhof, I.M. Rietjens, and G.M. Alink. 2010. “Role of Surface Charge and Oxidative Stress in Cytotoxicity of Organic Monolayer-Coated Silicon Nanoparticles towards Macrophage NR8383 Cells.” Particle and Fibre Toxicology 7(1): 25. doi:10.1186/1743-8977-7-25.
   PubMedGoogle Scholar
• Bhattacharjee, S., I. M. Rietjens, M. P. Singh, T. M. Atkins, T. K. Purkait, Z. Xu, S. Regli, et al. 2013. “Cytotoxicity of Surface-Functionalized Silicon and Germanium Nanoparticles: The Dominant Role of Surface Charges.” Nanoscale 5(11): 4870–4883. doi:10.1039/c3nr34266b.
   PubMed Web of Science ®Google Scholar
• Bianchi, A., S. Dufort, F. Lux, P. Y. Fortin, N. Tassali, O. Tillement, J. L. Coll, and Y. Cremillieux. 2014. “Targeting and in Vivo Imaging of Non-Small-Cell Lung Cancer Using Nebulized Multimodal Contrast Agents.” Proceedings of the National Academy of Sciences 111(25): 9247–9252. doi:10.1073/pnas.1402196111.
   PubMed Web of Science ®Google Scholar
• Bisgaard, H., C. O'callaghan, and G. Smaldone. 1999. Drug delivery to the lung. Boca Raton: CRC Press.
   Google Scholar
• Bohr, A., J. Water, M. Beck-Broichsitter, and M. Yang. 2015. “Nanoembedded Microparticles for Stabilization and Delivery of Drug-Loaded Nanoparticles.” Current Pharmaceutical Design 21(40): 5829–5844. doi:10.2174/1381612821666151008124322.
   PubMed Web of Science ®Google Scholar
• Bourquin, J., A. Milosevic, D. Hauser, R. Lehner, F. Blank, A. Petri-Fink, and B. Rothen-Rutishauser. 2018. “Biodistribution, Clearance, and Long-Term Fate of Clinically Relevant Nanomaterials.” Advanced Materials 30(19): 1704307. doi:10.1002/adma.201704307.
   Web of Science ®Google Scholar
• Braakhuis, H. M., F. R. Cassee, P. H. Fokkens, L. J. De La Fonteyne, A. G. Oomen, P. Krystek, W. H. De Jong, H. Van Loveren, and M. V. Park. 2016. “Identification of the Appropriate Dose Metric for Pulmonary Inflammation of Silver Nanoparticles in an Inhalation Toxicity Study.” Nanotoxicology 10: 63–73. doi:10.3109/17435390.2015.1012184.
   PubMed Web of Science ®Google Scholar
• Braakhuis, H. M., M. V. Park, I. Gosens, W. H. De Jong, and F. R. Cassee. 2014. “Physicochemical Characteristics of Nanomaterials That Affect Pulmonary Inflammation.” Particle and Fibre Toxicology 11(1): 18. doi:10.1186/1743-8977-11-18.
   PubMedGoogle Scholar
• Braydich-Stolle, L. K., E. K. Breitner, K. K. Comfort, J. J. Schlager, and S. M. Hussain. 2014. “Dynamic Characteristics of Silver Nanoparticles in Physiological Fluids: Toxicological Implications.” Langmuir 30(50): 15309–15316. doi:10.1021/la5036079.
   PubMed Web of Science ®Google Scholar
• Braydich-Stolle, L. K., N. M. Schaeublin, R. C. Murdock, J. Jiang, P. Biswas, J. J. Schlager, and S. M. Hussain. 2009. “Crystal Structure Mediates Mode of Cell Death in TiO2 Nanotoxicity.” Journal of Nanoparticle Research 11(6): 1361–1374. doi:10.1007/s11051-008-9523-8.
   Web of Science ®Google Scholar
• Buzea, C., I. Pacheco, and K. Robbie. 2007. “Nanomaterials and Nanoparticles: Sources and Toxicity.” Biointerphases 2(4): Mr17–71.
   PubMed Web of Science ®Google Scholar
• Byrne, A. J., S. A. Mathie, L. G. Gregory, and C. M. Lloyd. 2015. “Pulmonary Macrophages: Key Players in the Innate Defence of the Airways.” Thorax 70(12): 1189–1196. doi:10.1136/thoraxjnl-2015-207020.
   PubMed Web of Science ®Google Scholar
• Cao, X., Y. Han, F. Li, Z. Li, D. J. Mcclements, L. He, E. A. Decker, B. Xing, and H. Xiao. 2019. “Impact of Protein-Nanoparticle Interactions on Gastrointestinal Fate of Ingested Nanoparticles: Not Just Simple Protein Corona Effects.” NanoImpact 13: 37–43. doi:10.1016/j.impact.2018.12.002.
   Web of Science ®Google Scholar
• Chandel, A., A. K. Goyal, G. Ghosh, and G. Rath. 2019. “Recent Advances in Aerosolised Drug Delivery.” Biomedicine and Pharmacotherapy 112: 108601. doi:10.1016/j.biopha.2019.108601.
   PubMed Web of Science ®Google Scholar
• Chauhan, R., and N. Sood. 2016. “Biopharmaceuticals: New Yet Natural.” British Biotechnology Journal 14(1): 1–19. doi:10.9734/BBJ/2016/25742.
   Google Scholar
• Chavda, V. P. 2019. “Chapter 4 – Nanobased Nano Drug Delivery: A Comprehensive Review.” In Applications of Targeted Nano Drugs and Delivery Systems, edited by S. S. Mohapatra, S. Ranjan, N. Dasgupta, R. K. Mishra and S. Thomas, 69–92. Netherlands: Elsevier.
   Google Scholar
• Chen, Z. P., M. Li, L. J. Zhang, J. Y. He, L. Wu, Y. Y. Xiao, J. A. Duan, T. Cai, and W. D. Li. 2016. “Mitochondria-Targeted Drug Delivery System for Cancer Treatment.” Journal of Drug Targeting 24(6): 492–502. doi:10.3109/1061186X.2015.1108325.
   PubMed Web of Science ®Google Scholar
• Chhowalla, M., H. E. Unalan, Y. B. Wang, Z. Iqbal, K. Park, and F. Sesti. 2005. “Irreversible Blocking of Ion Channels Using Functionalized Single-Walled Carbon Nanotubes.” Nanotechnology 16(12): 2982–2986. doi:10.1088/0957-4484/16/12/042.
   Web of Science ®Google Scholar
• Cho, W. S., F. Thielbeer, R. Duffin, E. M. Johansson, I. L. Megson, W. Macnee, M. Bradley, and K. Donaldson. 2014. “Surface Functionalization Affects the Zeta Potential, Coronal Stability and Membranolytic Activity of Polymeric Nanoparticles.” Nanotoxicology 8(2): 202–211. doi:10.3109/17435390.2013.773465.
   PubMed Web of Science ®Google Scholar
• Choi, S. H., H. J. Byeon, J. S. Choi, L. Thao, I. Kim, E. S. Lee, B. S. Shin, K. C. Lee, and Y. S. Youn. 2015. “Inhalable Self-Assembled Albumin Nanoparticles for Treating Drug-Resistant Lung Cancer.” Journal of Controlled Release 197: 199–207. doi:10.1016/j.jconrel.2014.11.008.
   PubMed Web of Science ®Google Scholar
• Chono, S., T. Tanino, T. Seki, and K. Morimoto. 2006. “Influence of Particle Size on Drug Delivery to Rat Alveolar Macrophages following Pulmonary Administration of Ciprofloxacin Incorporated into Liposomes.” Journal of Drug Targeting 14(8): 557–566. doi:10.1080/10611860600834375.
   PubMed Web of Science ®Google Scholar
• Conner, S. D., and S. L. Schmid. 2003. “Regulated Portals of Entry into the Cell.” Nature 422(6927): 37–44. doi:10.1038/nature01451.
   PubMed Web of Science ®Google Scholar
• Corcoran, T. E., R. Niven, W. Verret, S. Dilly, and B. A. Johnson. 2014. “Lung Deposition and Pharmacokinetics of Nebulized Cyclosporine in Lung Transplant Patients.” Journal of Aerosol Medicine and Pulmonary Drug Delivery 27(3): 178–184. doi:10.1089/jamp.2013.1042.
   PubMed Web of Science ®Google Scholar
• Costa-Gouveia, J., E. Pancani, S. Jouny, A. Machelart, V. Delorme, G. Salzano, R. Iantomasi, et al. 2017. “Combination Therapy for Tuberculosis Treatment: Pulmonary Administration of Ethionamide and Booster co-Loaded Nanoparticles.” Scientific Reports 7(1): 5390. doi:10.1038/s41598-017-05453-3.
   PubMed Web of Science ®Google Scholar
• Coty, J. B., and C. Vauthier. 2018. “Characterization of Nanomedicines: A Reflection on a Field under Construction Needed for Clinical Translation Success.” Journal of Controlled Release 275: 254–268. doi:10.1016/j.jconrel.2018.02.013.
   PubMed Web of Science ®Google Scholar
• Darquenne, C. 2012. “Aerosol Deposition in Health and Disease.” Journal of Aerosol Medicine and Pulmonary Drug Delivery 25(3): 140–147. doi:10.1089/jamp.2011.0916.
   PubMed Web of Science ®Google Scholar
• De Boer, A. H., D. Gjaltema, P. Hagedoorn, and H. W. Frijlink. 2002. “Characterization of Inhalation Aerosols: A Critical Evaluation of Cascade Impactor Analysis and Laser Diffraction Technique.” International Journal of Pharmaceutics 249(1–2): 219–231. doi:10.1016/S0378-5173(02)00526-4.
   PubMed Web of Science ®Google Scholar
• De Boer, A. H., P. Hagedoorn, M. Hoppentocht, F. Buttini, F. Grasmeijer, and H. W. Frijlink. 2017. “Dry Powder Inhalation: Past, Present and Future.”Expert Opinion on Drug Delivery 14(4): 499–512. doi:10.1080/17425247.2016.1224846.
   PubMed Web of Science ®Google Scholar
• De Jong, W. H., and P. J. Borm. 2008. “Drug Delivery and Nanoparticles: Applications and Hazards.” International Journal of Nanomedicine 3(2): 133–149.
   PubMed Web of Science ®Google Scholar
• De Matteis, V. 2017. “Exposure to Inorganic Nanoparticles: Routes of Entry, Immune Response, Biodistribution and in Vitro/in Vivo Toxicity Evaluation.” Toxics 5(4): 29. doi:10.3390/toxics5040029.
   PubMed Web of Science ®Google Scholar
• De Stefano, D., R. Carnuccio, and M. C. Maiuri. 2012. “Nanomaterials Toxicity and Cell Death Modalities.” Journal of Drug Delivery 2012: 167896. doi:10.1155/2012/167896.
   PubMedGoogle Scholar
• Depreter, F. M., G. Pilcer, and K. Amighi. 2013. “Inhaled Proteins: Challenges and Perspectives.” International Journal of Pharmaceutics 447(1–2): 251–280. doi:10.1016/j.ijpharm.2013.02.031.
   PubMed Web of Science ®Google Scholar
• Doak, S. H., and M. Dusinska. 2017. “NanoGenotoxicology: Present and the Future.” Mutagenesis 32(1): 1–4. doi:10.1093/mutage/gew066.
   PubMed Web of Science ®Google Scholar
• Dolovich, M. B., and R. Dhand. 2011. “Aerosol Drug Delivery: Developments in Device Design and Clinical Use.” Lancet (London, England) 377(9770): 1032–1045. doi:10.1016/S0140-6736(10)60926-9.
   PubMed Web of Science ®Google Scholar
• Dominska, M., and D. M. Dykxhoorn. 2010. “Breaking Down the Barriers: SiRNA Delivery and Endosome Escape.” Journal of Cell Science 123(Pt 8): 1183–1189. doi:10.1242/jcs.066399.
   PubMed Web of Science ®Google Scholar
• Donahue, N. D., H. Acar, and S. Wilhelm. 2019. “Concepts of Nanoparticle Cellular Uptake, Intracellular Trafficking, and Kinetics in Nanomedicine.” Advanced Drug Delivery Reviews. doi:10.1016/j.addr.2019.04.008.
   PubMed Web of Science ®Google Scholar
• Donaldson, K., P. H. Beswick, and P. S. Gilmour. 1996. “Free Radical Activity Associated with the Surface of Particles: A Unifying Factor in Determining Biological Activity?” Toxicology Letters 88(1–3): 293–298. doi:10.1016/0378-4274(96)03752-6.
   PubMed Web of Science ®Google Scholar
• Donaldson, K., P. J. Borm, V. Castranova, and M. Gulumian. 2009. “The Limits of Testing Particle-Mediated Oxidative Stress in Vitro in Predicting Diverse Pathologies; Relevance for Testing of Nanoparticles.” Particle and Fibre Toxicology 6(1): 13. doi:10.1186/1743-8977-6-13.
   PubMedGoogle Scholar
• Donaldson, K., V. Stone, C. L. Tran, W. Kreyling, and P. J. Borm. 2004. “Nanotoxicology.” Occupational and Environmental Medicine 61(9): 727–728. doi:10.1136/oem.2004.013243.
   PubMed Web of Science ®Google Scholar
• Drasler, B., P. Sayre, K. G. Steinhauser, A. Petri-Fink, and B. Rothen-Rutishauser. 2017. “In Vitro Approaches to Assess the Hazard of Nanomaterials.” Nanoimpact 8: 99–116. doi:10.1016/j.impact.2017.08.002.
   Web of Science ®Google Scholar
• Drescher, D., G. Orts-Gil, G. Laube, K. Natte, R.W. Veh, W. Osterle, and J. Kneipp. 2011. “Toxicity of Amorphous Silica Nanoparticles on Eukaryotic Cell Model Is Determined by Particle Agglomeration and Serum Protein Adsorption Effects.” Analytical and Bioanalytical Chemistry 400(5): 1367–1373. doi:10.1007/s00216-011-4893-7.
   PubMed Web of Science ®Google Scholar
• Driscoll, K. E., J. M. Carter, B. W. Howard, D. G. Hassenbein, W. Pepelko, R. B. Baggs, and G. Oberdorster. 1996. “Pulmonary Inflammatory, Chemokine, and Mutagenic Responses in Rats after Subchronic Inhalation of Carbon Black.” Toxicology and Applied Pharmacology 136(2): 372–380. doi:10.1006/taap.1996.0045.
   PubMed Web of Science ®Google Scholar
• Dufort, S., A. Bianchi, M. Henry, F. Lux, G. Le Duc, V. Josserand, C. Louis, et al. 2015. “Nebulized Gadolinium-Based Nanoparticles: A Theranostic Approach for Lung Tumor Imaging and Radiosensitization.” Small 11(2): 215–221. doi:10.1002/smll.201401284.
   PubMed Web of Science ®Google Scholar
• Eftekhari, A. 2018. “The Application of Novel Mitochondria-Targeted Antioxidants: Current Strategies and Future Perspectives.” Journal of Advanced Chemical and Pharmaceutical Materials 1: 1–2.
   Google Scholar
• Elkin, S. R., A. M. Lakoduk, and S. L. Schmid. 2016. “Endocytic Pathways and Endosomal Trafficking: A Primer.” Wiener Medizinische Wochenschrift (1946) 166(7–8): 196–204. doi:10.1007/s10354-016-0432-7.
   PubMed Web of Science ®Google Scholar
• Ely, L., W. Roa, W. H. Finlay, and R. Lobenberg. 2007. “Effervescent Dry Powder for Respiratory Drug Delivery.” European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik e.V 65(3): 346–353. doi:10.1016/j.ejpb.2006.10.021.
   PubMed Web of Science ®Google Scholar
• Evans, S. J., G. J. Jenkins, S. H. Doak, and M. J. Clift. 2019. “Cellular Defense Mechanisms following Nanomaterial Exposure: A Focus on Oxidative Stress and Cytotoxicity.” In NanoScience and Technology - Biological Responses to Nanoscale Particles, edited by P. Gehr and R. Zellner, 243–254. Cham: Springer.
   Google Scholar
• Farnoud, A. M., and S. Nazemidashtarjandi. 2019. “Emerging Investigator Series: Interactions of Engineered Nanomaterials with the Cell Plasma Membrane; What Have we Learned from Membrane Models?” Environmental Science: Nano 6(1): 13–40. doi:10.1039/C8EN00514A.
   Web of Science ®Google Scholar
• Forest, V., J. Pourchez, C. Guibert, D. Bitounis, L. Leclerc, G. Sarry, and J.-M. Vergnon. 2019. “Nano to Micron-Sized Particle Detection in Patients' Lungs and Its Pathological Significance.” Environmental Science: Nano 6: 1343–1350. doi:10.1039/C8EN01301B.
   Web of Science ®Google Scholar
• Forest, V., J.-M. Vergnon, and J. Pourchez. 2017. “Biological Monitoring of Inhaled Nanoparticles in Patients: An Appealing Approach to Study Causal Link between Human Respiratory Pathology and Exposure to Nanoparticles.” Chemical Research in Toxicology 30(9): 1655. doi:10.1021/acs.chemrestox.7b00192.
   PubMed Web of Science ®Google Scholar
• Foss Hansen, S., L. R. Heggelund, P. Revilla Besora, A. Mackevica, A. Boldrin, and A. Baun. 2016. “Nanoproducts – What Is Actually Available to European Consumers?” Environmental Science: Nano 3: 169–180. doi:10.1039/C5EN00182J.
   Web of Science ®Google Scholar
• Fröhlich, E., and S. Salar-Behzadi. 2014. “Toxicological Assessment of Inhaled Nanoparticles: Role of in Vivo, Ex Vivo, in Vitro, and in Silico Studies.” International Journal of Molecular Sciences 15(3): 4795–4822. doi:10.3390/ijms15034795.
   PubMed Web of Science ®Google Scholar
• Fu, P. P., Q. Xia, H. M. Hwang, P. C. Ray, and H. Yu. 2014. “Mechanisms of Nanotoxicity: Generation of Reactive Oxygen Species.” Journal of Food and Drug Analysis 22(1): 64–75. doi:10.1016/j.jfda.2014.01.005.
   PubMed Web of Science ®Google Scholar
• Gaggar, A., J. Chen, J. F. Chmiel, H. L. Dorkin, P. A. Flume, R. Griffin, D. Nichols, and S. H. Donaldson. 2016. “Inhaled alpha1-Proteinase Inhibitor Therapy in Patients with Cystic Fibrosis.” Journal of Cystic Fibrosis 15(2): 227–233. doi:10.1016/j.jcf.2015.07.009.
   PubMed Web of Science ®Google Scholar
• Gatoo, M. A., S. Naseem, M. Y. Arfat, A. Mahmood Dar, K. Qasim, and S. Zubair. 2014. “Physicochemical Properties of Nanomaterials: Implication in Associated Toxic Manifestations.” BioMed Research International 2014: 1. doi:10.1155/2014/498420.
   Web of Science ®Google Scholar
• Gaul, R., J. M. Ramsey, A. Heise, S.-A. Cryan, and C. M. Greene. 2018. “Nanotechnology Approaches to Pulmonary Drug Delivery: Targeted Delivery of Small Molecule and Gene-Based Therapeutics to the Lung.” In Design of nanostructures for versatile therapeutic applications, edited by A. M. Grumezescu, 221–253. New York, NY: William Andrew Publishing.
   Google Scholar
• Gibson, G.J., R. Loddenkemper, B. Lundbäck, and Y. Sibille, 2013. “Respiratory Health and Disease in Europe: The New European Lung White Book.” The European Respiratory Journal 42 (3): 559–563.
   PubMed Web of Science ®Google Scholar
• Gill, K. K., S. Nazzal, and A. Kaddoumi. 2011. “Paclitaxel Loaded PEG(5000)-DSPE Micelles as Pulmonary Delivery Platform: Formulation Characterization, Tissue Distribution, Plasma Pharmacokinetics, and Toxicological Evaluation.” European Journal of Pharmaceutics and Biopharmaceutics 79(2): 276–284. doi:10.1016/j.ejpb.2011.04.017.
   PubMed Web of Science ®Google Scholar
• Godugu, C., A. R. Patel, R. Doddapaneni, S. Marepally, T. Jackson, and M. Singh. 2013. “Inhalation Delivery of Telmisartan Enhances Intratumoral Distribution of Nanoparticles in Lung Cancer Models.” Journal of Controlled Release 172(1): 86–95. doi:10.1016/j.jconrel.2013.06.036.
   PubMed Web of Science ®Google Scholar
• Gordon, S., and R. Read. 2002. “Macrophage Defences against Respiratory Tract Infections.” British Medical Bulletin 61(1): 45–61. doi:10.1093/bmb/61.1.45.
   PubMedGoogle Scholar
• Han, X., K. Xu, O. Taratula, and K. Farsad. 2019. “Applications of Nanoparticles in Biomedical Imaging.” Nanoscale 11(3): 799–819. doi:10.1039/c8nr07769j.
   PubMed Web of Science ®Google Scholar
• Heyder, J. 2004. “Deposition of Inhaled Particles in the Human Respiratory Tract and Consequences for Regional Targeting in Respiratory Drug Delivery.” Proceedings of the American Thoracic Society 1(4): 315–320. doi:10.1513/pats.200409-046TA.
   PubMedGoogle Scholar
• Hohenegger, M. 2010. “Novel and Current Treatment Concepts Using Pulmonary Drug Delivery.” Current Pharmaceutical Design 16(22): 2484–2492. doi:10.2174/138161210791959890.
   PubMed Web of Science ®Google Scholar
• Hoppentocht, M., P. Hagedoorn, H. W. Frijlink, and A. H. De Boer. 2014. “Technological and Practical Challenges of Dry Powder Inhalers and Formulations.” Advanced Drug Delivery Reviews 75: 18–31. doi:10.1016/j.addr.2014.04.004.
   PubMed Web of Science ®Google Scholar
• Hu, J., Y. Dong, G. Pastorin, W. K. Ng, and R. B. H. Tan. 2013. “Spherical Agglomerates of Pure Drug Nanoparticles for Improved Pulmonary Delivery in Dry Powder Inhalers.” Journal of Nanoparticle Research 15(4): 15–60. doi:10.1007/s11051-013-1560-2.
   Web of Science ®Google Scholar
• Hughes, P., D. Marshall, Y. Reid, H. Parkes, and C. Gelber. 2007. “The Costs of Using Unauthenticated, over-Passaged Cell Lines: How Much More Data Do we Need?” Biotechniques 43(5): 575, 577–578. doi:10.2144/000112598.
   Web of Science ®Google Scholar
• Hu, G., B. Jiao, X. Shi, R. P. Valle, Q. Fan, and Y. Y. Zuo. 2013. “Physicochemical Properties of Nanoparticles Regulate Translocation across Pulmonary Surfactant Monolayer and Formation of Lipoprotein Corona.” ACS Nano 7(12): 10525–10533. doi:10.1021/nn4054683.
   PubMed Web of Science ®Google Scholar
• Hu, L., Y. Jia, and  Wending. 2010. “Preparation and Characterization of Solid Lipid Nanoparticles Loaded with Epirubicin for Pulmonary Delivery.” Pharmazie 65: 585–587.
   PubMed Web of Science ®Google Scholar
• Ihalainen, M., P. Jalava, T. Ihantola, S. Kasurinen, O. Uski, O. Sippula, A. Hartikainen, et al. 2019. “Design and Validation of an Air-Liquid Interface (ALI) Exposure Device Based on Thermophoresis.” Aerosol Science and Technology 53(2): 133–145. doi:10.1080/02786826.2018.1556775.
   Web of Science ®Google Scholar
• Insmed. 2019. Arikayce [online]. http://investor.insmed.com/news-releases/news-release-details/insmed-announces-fda-approval-arikaycer-amikacin-liposome. Accessed 2018.
   Google Scholar
• Iyer, R., C. C. W. Hsia, and K. T. Nguyen. 2015. “Nano-Therapeutics for the Lung: State-of-the-Art and Future Perspectives.” Current Pharmaceutical Design 21(36): 5233–5244. doi:10.2174/1381612821666150923095742.
   PubMed Web of Science ®Google Scholar
• Jakubek, L. M., S. Marangoudakis, J. Raingo, X. Liu, D. Lipscombe, and R. H. Hurt. 2009. “The Inhibition of Neuronal Calcium Ion Channels by Trace Levels of Yttrium Released from Carbon Nanotubes.” Biomaterials 30(31): 6351–6357. doi:10.1016/j.biomaterials.2009.08.009.
   PubMed Web of Science ®Google Scholar
• Jameson, C. J., P. Oroskar, B. Song, H. Yuan, and S. Murad. 2019. “Molecular Dynamics Studies of Nanoparticle Transport through Model Lipid Membranes.” Biomimetic Lipid Membranes: Fundamentals, Applications, and Commercialization. 109–165.
   Google Scholar
• Jan, E., S. J. Byrne, M. Cuddihy, A. M. Davies, Y. Volkov, Y. K. Gun'ko, and N. A. Kotov. 2008. “High-Content Screening as a Universal Tool for Fingerprinting of Cytotoxicity of Nanoparticles.” ACS Nano 2(5): 928–938. doi:10.1021/nn7004393.
   PubMed Web of Science ®Google Scholar
• Jantunen, A. P. K., S. Gottardo, K. Rasmussen, and H. P. Crutzen. 2018. “An Inventory of Ready-to-Use and Publicly Available Tools for the Safety Assessment of Nanomaterials.” NanoImpact 12: 18–28. doi:10.1016/j.impact.2018.08.007.
   PubMed Web of Science ®Google Scholar
• Jeong, Y. S., W. K. Oh, S. Kim, and J. Jang. 2011. “Cellular Uptake, Cytotoxicity, and ROS Generation with Silica/Conducting Polymer Core/Shell Nanospheres.” Biomaterials 32(29): 7217–7225. doi:10.1016/j.biomaterials.2011.06.020.
   PubMed Web of Science ®Google Scholar
• Jiang, X., C. Rocker, M. Hafner, S. Brandholt, R. M. Dorlich, and G. U. Nienhaus. 2010. “Endo- and Exocytosis of Zwitterionic Quantum Dot Nanoparticles by Live HeLa Cells.” ACS Nano 4(11): 6787–6797. doi:10.1021/nn101277w.
   PubMed Web of Science ®Google Scholar
• Jones, C. F., and D. W. Grainger. 2009. “In Vitro Assessments of Nanomaterial Toxicity.” Advanced Drug Delivery Reviews 61(6): 438–456. doi:10.1016/j.addr.2009.03.005.
   PubMed Web of Science ®Google Scholar
• Joris, F., B. B. Manshian, K. Peynshaert, S. C. De Smedt, K. Braeckmans, and S. J. Soenen. 2013. “Assessing Nanoparticle Toxicity in Cell-Based Assays: Influence of Cell Culture Parameters and Optimized Models for Bridging the in Vitro-in Vivo Gap.” Chemical Society Reviews 42(21): 8339–8359. doi:10.1039/c3cs60145e.
   PubMed Web of Science ®Google Scholar
• Jyoti, K., K. Kaur, R. S. Pandey, U. K. Jain, R. Chandra, and J. Madan. 2015. “Inhalable Nanostructured Lipid Particles of 9-Bromo-Noscapine, a Tubulin-Binding Cytotoxic Agent: In Vitro and in Vivo Studies.” Journal of Colloid and Interface Science 445: 219–230. doi:10.1016/j.jcis.2014.12.092.
   PubMed Web of Science ®Google Scholar
• Kalaydina, R.-V., K. Bajwa, B. Qorri, A. Decarlo, and M. R. Szewczuk. 2018. “Recent Advances in “Smart” Delivery Systems for Extended Drug Release in Cancer Therapy.” International Journal of Nanomedicine 13: 4727–4745. doi:10.2147/IJN.S168053.
   PubMed Web of Science ®Google Scholar
• Kaminskas, L. M., V. M. Mcleod, G. M. Ryan, B. D. Kelly, J. M. Haynes, M. Williamson, N. Thienthong, D. J. Owen, and C. J. Porter. 2014. “Pulmonary Administration of a Doxorubicin-Conjugated Dendrimer Enhances Drug Exposure to Lung Metastases and Improves Cancer Therapy.” Journal of Controlled Release 183: 18–26. doi:10.1016/j.jconrel.2014.03.012.
   PubMed Web of Science ®Google Scholar
• Kasper, J. Y., L. Feiden, M. I. Hermanns, C. Bantz, M. Maskos, R. E. Unger, and C. J. Kirkpatrick. 2015. “Pulmonary Surfactant Augments Cytotoxicity of Silica Nanoparticles: Studies on an in Vitro Air-Blood Barrier Model.” Beilstein Journal of Nanotechnology 6: 517–528. doi:10.3762/bjnano.6.54.
   PubMed Web of Science ®Google Scholar
• Kim, Y. K., L. Xing, B. A. Chen, F. Xu, H. L. Jiang, and C. Zhang. 2014. “Aerosol Delivery of Programmed Cell Death Protein 4 Using Polysorbitol-Based Gene Delivery System for Lung Cancer Therapy.” Journal of Drug Targeting 22(9): 829–838. doi:10.3109/1061186X.2014.932796.
   PubMed Web of Science ®Google Scholar
• Kleinstreuer, C., Z. Zhang, and J. F. Donohue. 2008. “Targeted Drug-Aerosol Delivery in the Human Respiratory System.” Annual Review of Biomedical Engineering 10(1): 195–220. doi:10.1146/annurev.bioeng.10.061807.160544.
   PubMedGoogle Scholar
• Kreyling, W. G., U. Holzwarth, N. Haberl, J. Kozempel, S. Hirn, A. Wenk, C. Schleh, et al. 2017. “Quantitative Biokinetics of Titanium Dioxide Nanoparticles after Intravenous Injection in Rats: Part 1.” Nanotoxicology 11(4): 434–442. doi:10.1080/17435390.2017.1306892.
   PubMed Web of Science ®Google Scholar
• Kreyling, W. G., U. Holzwarth, N. Haberl, J. Kozempel, A. Wenk, S. Hirn, C. Schleh, et al. 2017. “Quantitative Biokinetics of Titanium Dioxide Nanoparticles after Intratracheal Instillation in Rats: Part 3.” Nanotoxicology 11(4): 454–464. doi:10.1080/17435390.2017.1306894.
   PubMed Web of Science ®Google Scholar
• Kreyling, W. G., U. Holzwarth, C. Schleh, J. Kozempel, A. Wenk, N. Haberl, S. Hirn, et al. 2017. “Quantitative Biokinetics of Titanium Dioxide Nanoparticles after Oral Application in Rats: Part 2.” Nanotoxicology 11(4): 443–453. doi:10.1080/17435390.2017.1306893.
   PubMed Web of Science ®Google Scholar
• Kroon, L. A. 2007. “Drug Interactions with Smoking.” American Journal of Health-System Pharmacy: Official Journal of the American Society of Health-System Pharmacists 64(18): 1917–1921. doi:10.2146/ajhp060414.
   PubMed Web of Science ®Google Scholar
• Kuhlbusch, T. A., S. W. Wijnhoven, and A. Haase. 2018. “Nanomaterial Exposures for Worker, Consumer and the General Public.” NanoImpact 10: 11–25. doi:10.1016/j.impact.2017.11.003.
   Web of Science ®Google Scholar
• Kunda, N. K., I. M. Alfagih, E. N. Miyaji, D. B. Figueiredo, V. M. Goncalves, D. M. Ferreira, S. R. Dennison, S. Somavarapu, G. A. Hutcheon, and I. Y. Saleem. 2015. “Pulmonary Dry Powder Vaccine of Pneumococcal Antigen Loaded Nanoparticles.” International Journal of Pharmaceutics 495(2): 903–912. doi:10.1016/j.ijpharm.2015.09.034.
   PubMed Web of Science ®Google Scholar
• Kunda, N. K., S. Somavarapu, S. B. Gordon, G. A. Hutcheon, and I. Y. Saleem. 2013. “Nanocarriers Targeting Dendritic Cells for Pulmonary Vaccine Delivery.” Pharmaceutical Research 30(2): 325–341. doi:10.1007/s11095-012-0891-5.
   PubMed Web of Science ®Google Scholar
• Labiris, N. R., and M. B. Dolovich. 2003. “Pulmonary Drug Delivery. Part I: Physiological Factors Affecting Therapeutic Effectiveness of Aerosolized Medications.” British Journal of Clinical Pharmacology 56(6): 588–599. doi:10.1046/j.1365-2125.2003.01892.x.
   PubMed Web of Science ®Google Scholar
• Lacroix, G., W. Koch, D. Ritter, A. C. Gutleb, S. T. Larsen, T. Loret, F. Zanetti, S. Constant, S. Chortarea, B. Rothen-Rutishauser., et al. 2018. “Air–Liquid Interface in Vitro Models for Respiratory Toxicology Research: Consensus Workshop and Recommendations.” Applied in Vitro Toxicology 4(2): 91–106. doi:10.1089/aivt.2017.0034.
   PubMedGoogle Scholar
• Lamon, L., K. Aschberger, D. Asturiol, A. Richarz, and A. Worth. 2019. “Grouping of Nanomaterials to Read-across Hazard Endpoints: A Review.” Nanotoxicology 13(1): 100–118. doi:10.1080/17435390.2018.1506060.
   PubMed Web of Science ®Google Scholar
• Lemaire, F., C. A. Mandon, J. Reboud, A. Papine, J. Angulo, H. Pointu, C. Diaz-Latoud, et al. 2007. “Toxicity Assays in Nanodrops Combining Bioassay and Morphometric Endpoints.” PLOS One 2(1): E163. doi:10.1371/journal.pone.0000163.
   PubMed Web of Science ®Google Scholar
• Lewinski, N., V. Colvin, and R. Drezek. 2008. “Cytotoxicity of Nanoparticles.” Small (Weinheim an Der Bergstrasse, Germany) 4(1): 26–49. doi:10.1002/smll.200700595.
   PubMed Web of Science ®Google Scholar
• Li, Y., Q. Cheng, Q. Jiang, Y. Huang, H. Liu, Y. Zhao, W. Cao, et al. 2014. “Enhanced Endosomal/Lysosomal Escape by Distearoyl Phosphoethanolamine-Polycarboxybetaine Lipid for Systemic Delivery of siRNA.” Journal of Controlled Release 176: 104–114. doi:10.1016/j.jconrel.2013.12.007.
   PubMed Web of Science ®Google Scholar
• Li, R., Z. Ji, H. Qin, X. Kang, B. Sun, M. Wang, C.H. Chang, et al. 2014. “Interference in Autophagosome Fusion by Rare Earth Nanoparticles Disrupts Autophagic Flux and Regulation of an Interleukin-1 Beta Producing Inflammasome.” ACS Nano 8(10): 10280–10292. doi:10.1021/nn505002w.
   PubMed Web of Science ®Google Scholar
• Li, L., X. Li, Y. Wu, L. Song, X. Yang, T. He, N. Wang, et al. 2017. “Multifunctional Nucleus-Targeting Nanoparticles with Ultra-High Gene Transfection Efficiency for in Vivo Gene Therapy.” Theranostics 7(6): 1633–1649. doi:10.7150/thno.17588.
   PubMed Web of Science ®Google Scholar
• Limbach, L. K., Y. Li, R. N. Grass, T. J. Brunner, M. A. Hintermann, M. Muller, D. Gunther, and W. J. Stark. 2005. “Oxide Nanoparticle Uptake in Human Lung Fibroblasts: Effects of Particle Size, Agglomeration, and Diffusion at Low Concentrations.” Environmental Science and Technology 39(23): 9370–9376. doi:10.1021/es051043o.
   PubMed Web of Science ®Google Scholar
• Lin, S., X. Wang, Z. Ji, C. H. Chang, Y. Dong, H. Meng, Y. P. Liao, et al. 2014. “Aspect Ratio Plays a Role in the Hazard Potential of CeO2 Nanoparticles in Mouse Lung and Zebrafish Gastrointestinal Tract.” ACS Nano 8(5): 4450–4464. doi:10.1021/nn5012754.
   PubMed Web of Science ®Google Scholar
• Lin, C., X. Zhang, H. Chen, Z. Bian, G. Zhang, M. K. Riaz, D. Tyagi, et al. 2018. “Dual-Ligand Modified Liposomes Provide Effective Local Targeted Delivery of Lung-Cancer Drug by Antibody and Tumor Lineage-Homing Cell-Penetrating Peptide.”Drug Delivery 25(1): 256–266. doi:10.1080/10717544.2018.1425777.
   PubMed Web of Science ®Google Scholar
• Liu, W., Y. Wu, C. Wang, H. C. Li, T. Wang, C. Y. Liao, L. Cui, Q. F. Zhou, B. Yan, and G. B. Jiang. 2010. “Impact of Silver Nanoparticles on Human Cells: effect of Particle Size.” Nanotoxicology 4(3): 319–330. doi:10.3109/17435390.2010.483745.
   PubMed Web of Science ®Google Scholar
• Lombardo, D., M. A. Kiselev, and M. T. Caccamo. 2019. “Smart Nanoparticles for Drug Delivery Application: Development of Versatile Nanocarrier Platforms in Biotechnology and Nanomedicine.” Journal of Nanomaterials 2019: 1. doi:10.1155/2019/3702518.
   Web of Science ®Google Scholar
• Longmire, M., P. L. Choyke, and H. Kobayashi. 2008. “Clearance Properties of Nano-Sized Particles and Molecules as Imaging Agents: Considerations and Caveats.” Nanomedicine 3(5): 703–717. doi:10.2217/17435889.3.5.703.
   PubMed Web of Science ®Google Scholar
• Mangal, S., W. Gao, T. Li, and Q. T. Zhou. 2017. “Pulmonary Delivery of Nanoparticle Chemotherapy for the Treatment of Lung Cancers: Challenges and Opportunities.”Acta Pharmacologica Sinica 38(6): 782. doi:10.1038/aps.2017.34.
   PubMed Web of Science ®Google Scholar
• Mansour, H. M., Y. S. Rhee, and X. Wu. 2009. “Nanomedicine in Pulmonary Delivery.” International Journal of Nanomedicine 4: 299–319.
   PubMed Web of Science ®Google Scholar
• Mcbride, A. A., D. N. Price, and P. Muttil. 2017. “Pulmonary Delivery of Magnetically Targeted Nano-in-Microparticles.” In Cancer Nanotechnology. Methods in Molecular Biology, edited by R. Zeineldin, Vol. 1530, 369–378. New York, NY: Humana Press.
   Google Scholar
• Mcintosh, C. M., E. A. Esposito, 3rd, A. K. Boal, J. M. Simard, C. T. Martin, and V. M. Rotello. 2001. “Inhibition of DNA Transcription Using Cationic Mixed Monolayer Protected Gold Clusters.” Journal of the American Chemical Society 123(31): 7626–7629. doi:10.1021/ja015556g.
   PubMed Web of Science ®Google Scholar
• Medina, C., M. J. Santos-Martinez, A. Radomski, O. I. Corrigan, and M. W. Radomski. 2009. “Nanoparticles: Pharmacological and Toxicological Significance.” British Journal of Pharmacology 150(5): 552–558. doi:10.1038/sj.bjp.0707130.
   Web of Science ®Google Scholar
• Merisko-Liversidge, E. M., and G. G. Liversidge. 2008. “Drug Nanoparticles: Formulating Poorly Water-Soluble Compounds.” Toxicologic Pathology 36(1): 43–48. doi:10.1177/0192623307310946.
   PubMed Web of Science ®Google Scholar
• Miragoli, M., P. Ceriotti, M. Iafisco, M. Vacchiano, N. Salvarani, A. Alogna, P. Carullo, et al. 2018. “Inhalation of Peptide-Loaded Nanoparticles Improves Heart Failure.” Science Translational Medicine 10(424): eaan6205. doi:10.1126/scitranslmed.aan6205.
   PubMed Web of Science ®Google Scholar
• Mohammadinejad, R., M. A. Moosavi, S. Tavakol, D. O. Vardar, A. Hosseini, M. Rahmati, L. Dini, S. Hussain, A. Mandegary, and D. J. Klionsky. 2019. “Necrotic, Apoptotic and Autophagic Cell Fates Triggered by Nanoparticles.” Autophagy 15(1): 4–33. doi:10.1080/15548627.2018.1509171.
   PubMed Web of Science ®Google Scholar
• Monopoli, M. P., D. Walczyk, A. Campbell, G. Elia, I. Lynch, F. B. Bombelli, and K. A. Dawson. 2011. “Physical-Chemical Aspects of Protein Corona: Relevance to in Vitro and in Vivo Biological Impacts of Nanoparticles.” Journal of the American Chemical Society 133(8): 2525–2534. doi:10.1021/ja107583h.
   PubMed Web of Science ®Google Scholar
• Moore, T. L., L. Rodriguez-Lorenzo, V. Hirsch, S. Balog, D. Urban, C. Jud, B. Rothen-Rutishauser, M. Lattuada, and A. Petri-Fink. 2015. “Nanoparticle Colloidal Stability in Cell Culture Media and Impact on Cellular Interactions.” Chemical Society Reviews 44(17): 6287–6305. doi:10.1039/C4CS00487F.
   PubMed Web of Science ®Google Scholar
• Moraga-Espinoza, D., E. Eshaghian, and H. D. C. Smyth. 2018. “Mass Median Plume Angle: A Novel Approach to Characterize Plume Geometry in Solution Based pMDIs.” International Journal of Pharmaceutics 543(1–2): 376–385. doi:10.1016/j.ijpharm.2018.04.008.
   PubMed Web of Science ®Google Scholar
• Mu, Q., G. Jiang, L. Chen, H. Zhou, D. Fourches, A. Tropsha, and B. Yan. 2014. “Chemical Basis of Interactions between Engineered Nanoparticles and Biological Systems.” Chemical Reviews 114(15): 7740–7781. doi:10.1021/cr400295a.
   PubMed Web of Science ®Google Scholar
• Mura, S., H. Hillaireau, J. Nicolas, B. Le Droumaguet, C. Gueutin, S. Zanna, N. Tsapis, and E. Fattal. 2011. “Influence of Surface Charge on the Potential Toxicity of PLGA Nanoparticles towards Calu-3 Cells.” Int J Nanomedicine 6: 2591–2605.
   PubMed Web of Science ®Google Scholar
• Murata, M., K. Nakano, K. Tahara, Y. Tozuka, and H. Takeuchi. 2012. “Pulmonary Delivery of Elcatonin Using Surface-Modified Liposomes to Improve Systemic Absorption: Polyvinyl Alcohol with a Hydrophobic Anchor and Chitosan Oligosaccharide as Effective Surface Modifiers.” European Journal of Pharmaceutics and Biopharmaceutics 80(2): 340–346. doi:10.1016/j.ejpb.2011.10.011.
   PubMed Web of Science ®Google Scholar
• Myatt, G. J., E. Ahlberg, Y. Akahori, D. Allen, A. Amberg, L. T. Anger, A. Aptula, et al. 2018. “In Silico Toxicology Protocols.” Regulatory Toxicology and Pharmacology 96: 1–17.
   PubMed Web of Science ®Google Scholar
• Nel, A., T. Xia, H. Meng, X. Wang, S. Lin, Z. Ji, and H. Zhang. 2013. “Nanomaterial Toxicity Testing in the 21st Century: Use of a Predictive Toxicological Approach and High-Throughput Screening.” Accounts of Chemical Research 46(3): 607–621. doi:10.1021/ar300022h.
   PubMed Web of Science ®Google Scholar
• Nicod, L. 2005. “Lung Defences: An overview.” European Respiratory Review 14 (95): 45–50.
   Google Scholar
• Nierenberg, D., A. R. Khaled, and O. Flores. 2018. “Formation of a Protein Corona Influences the Biological Identity of Nanomaterials.” Reports of Practical Oncology & Radiotherapy 23(4): 300–308. doi:10.1016/j.rpor.2018.05.005.
   PubMedGoogle Scholar
• Nikula, K. J., M. B. Snipes, E. B. Barr, W. C. Griffith, R. F. Henderson, and J. L. Mauderly. 1995. “Comparative Pulmonary Toxicities and Carcinogenicities of Chronically Inhaled Diesel Exhaust and Carbon Black in F344 Rats.” Toxicological Sciences 25(1): 80–94. doi:10.1093/toxsci/25.1.80.
   Google Scholar
• Nowack, B. 2017. “Evaluation of Environmental Exposure Models for Engineered Nanomaterials in a Regulatory Context.”NanoImpact 8: 38–47. doi:10.1016/j.impact.2017.06.005.
   Web of Science ®Google Scholar
• Oberdorster, G., J. Ferin, and B. E. Lehnert. 1994. “Correlation between Particle Size, in Vivo Particle Persistence, and Lung Injury.” Environmental Health Perspectives 102(Suppl 5): 173–179. doi:10.1289/ehp.94102s5173.
   PubMed Web of Science ®Google Scholar
• Oberdorster, G., and T. A. J. Kuhlbusch. 2018. “In Vivo Effects: Methodologies and Biokinetics of Inhaled Nanomaterials.”Nanoimpact 10: 38–60. doi:10.1016/j.impact.2017.10.007.
   Web of Science ®Google Scholar
• Olsson, B., E. Bondesson, L. Borgström, S. Edsbäcker, S. Eirefelt, K. Ekelund, L. Gustavsson, and T. Hegelund-Myrbäck. 2011. “Pulmonary Drug Metabolism, Clearance, and Absorption.” In Controlled pulmonary drug delivery, edited by H. D. C. Smyth and A. J. Hickey, 21–50. New York, NY: Springer.
   Google Scholar
• Onoue, S., Y. Aoki, Y. Kawabata, T. Matsui, K. Yamamoto, H. Sato, Y. Yamauchi, and S. Yamada. 2011. “Development of Inhalable Nanocrystalline Solid Dispersion of Tranilast for Airway Inflammatory Diseases.” Journal of Pharmaceutical Sciences 100(2): 622–633. doi:10.1002/jps.22299.
   PubMed Web of Science ®Google Scholar
• Osman, N., K. Kaneko, V. Carini, and I. Saleem. 2018. “Carriers for the Targeted Delivery of Aerosolized Macromolecules for Pulmonary Pathologies.” Expert Opinion on Drug Delivery 15(8): 821–834. doi:10.1080/17425247.2018.1502267.
   PubMed Web of Science ®Google Scholar
• Pan, Y., A. Leifert, D. Ruau, S. Neuss, J. Bornemann, G. Schmid, W. Brandau, U. Simon, and W. Jahnen-Dechent. 2009. “Gold Nanoparticles of Diameter 1.4 nm Trigger Necrosis by Oxidative Stress and Mitochondrial Damage.” Small 5(18): 2067–2076. doi:10.1002/smll.200900466.
   PubMed Web of Science ®Google Scholar
• Pan, L., J. Liu, and J. Shi. 2018. “Cancer Cell Nucleus-Targeting Nanocomposites for Advanced Tumor Therapeutics.” Chemical Society Reviews 47(18): 6930–6946. doi:10.1039/C8CS00081F.
   PubMed Web of Science ®Google Scholar
• Patton, J. S. 1996. “Mechanisms of Macromolecule Absorption by the Lungs.” Advanced Drug Delivery Reviews 19(1): 3–36. doi:10.1016/0169-409X(95)00113-L.
   Web of Science ®Google Scholar
• Paur, H.-R., F. R. Cassee, J. Teeguarden, H. Fissan, S. Diabate, M. Aufderheide, W.G. Kreyling, et al. 2011. “In Vitro Cell Exposure Studies for the Assessment of Nanoparticle Toxicity in the Lung–A Dialog between Aerosol Science and Biology.” Journal of Aerosol Science 42(10): 668–692. doi:10.1016/j.jaerosci.2011.06.005.
   Web of Science ®Google Scholar
• Peetla, C., A. Stine, and V. Labhasetwar. 2009. “Biophysical Interactions with Model Lipid Membranes: Applications in Drug Discovery and Drug Delivery.” Molecular Pharmaceutics 6(5): 1264–1276. doi:10.1021/mp9000662.
   PubMed Web of Science ®Google Scholar
• Pietroiusti, A., H. Stockmann-Juvala, F. Lucaroni, and K. Savolainen. 2018. “Nanomaterial Exposure, Toxicity, and Impact on Human Health.” Wiley Interdisciplinary Reveiws: Nanomedicine and Nanobiotechnology. doi:10.1002/wnan.1513
   PubMed Web of Science ®Google Scholar
• Pilcer, G., and K. Amighi. 2010. “Formulation Strategy and Use of Excipients in Pulmonary Drug Delivery.” International Journal of Pharmaceutics 392(1–2): 1–19. doi:10.1016/j.ijpharm.2010.03.017.
   PubMed Web of Science ®Google Scholar
• Porter, D. W., N. Wu, A. F. Hubbs, R. R. Mercer, K. Funk, F. Meng, J. Li, et al. 2013. “Differential Mouse Pulmonary Dose and Time Course Responses to Titanium Dioxide Nanospheres and Nanobelts.” Toxicological Sciences 131(1): 179–193. doi:10.1093/toxsci/kfs261.
   PubMed Web of Science ®Google Scholar
• Pujalte, I., D. Dieme, S. Haddad, A. M. Serventi, and M. Bouchard. 2017. “Toxicokinetics of Titanium Dioxide (TiO2) Nanoparticles after Inhalation in Rats.” Toxicology Letters 265: 77–85. doi:10.1016/j.toxlet.2016.11.014.
   PubMed Web of Science ®Google Scholar
• Qiu, T. A., P. L. Clement, and C. L. Haynes. 2018. “Linking Nanomaterial Properties to Biological Outcomes: Analytical Chemistry Challenges in Nanotoxicology for the Next Decade.” Chemical Communications 54(91): 12787–12803. doi:10.1039/C8CC06473C.
   PubMed Web of Science ®Google Scholar
• Raesch, S. S., S. Tenzer, W. Storck, A. Rurainski, D. Selzer, C. A. Ruge, J. Perez-Gil, U. F. Schaefer, and C. M. Lehr. 2015. “Proteomic and Lipidomic Analysis of Nanoparticle Corona upon Contact with Lung Surfactant Reveals Differences in Protein, but Not Lipid Composition.” ACS Nano 9(12): 11872–11885. doi:10.1021/acsnano.5b04215.
   PubMed Web of Science ®Google Scholar
• Raies, A. B., and V. B. Bajic. 2016. “In Silico Toxicology: Computational Methods for the Prediction of Chemical Toxicity.” Wiley Interdisciplinary Reviews: Computational Molecular Science 6(2): 147–172. doi:10.1002/wcms.1240.
   PubMed Web of Science ®Google Scholar
• Railsback, J. G., A. Singh, R. C. Pearce, T. E. Mcknight, R. Collazo, Z. Sitar, Y. G. Yingling, and A. V. Melechko. 2012. “Weakly Charged Cationic Nanoparticles Induce DNA Bending and Strand Separation.” Advanced Materials 24(31): 4261–4265. doi:10.1002/adma.201104891.
   PubMed Web of Science ®Google Scholar
• Rangaraj, N., S. R. Pailla, and S. Sampathi. 2019. “Insight into Pulmonary Drug Delivery: Mechanism of Drug Deposition to Device Characterization and Regulatory Requirements.” Pulmonary Pharmacology and Therapeutics 54: 1–21. doi:10.1016/j.pupt.2018.11.004.
   PubMed Web of Science ®Google Scholar
• Rasmussen, K., H. Rauscher, P. Kearns, M. Gonzalez, and J. Riego Sintes. 2019. “Developing OECD Test Guidelines for Regulatory Testing of Nanomaterials to Ensure Mutual Acceptance of Test Data.” Regulatory Toxicology and Pharmacology 104: 74–83. doi:10.1016/j.yrtph.2019.02.008.
   PubMed Web of Science ®Google Scholar
• Ray, A., A. Mandal, and A. K. Mitra. 2015. “Recent Patents in Pulmonary Delivery of Macromolecules.” Recent Patents on Drug Delivery and Formulation 9(3): 225–236.
   PubMedGoogle Scholar
• Rinaldo, M., P. Andujar, A. Lacourt, L. Martinon, M. Canal Raffin, P. Dumortier, J. C. Pairon, and P. Brochard. 2015. “Perspectives in Biological Monitoring of Inhaled Nanosized Particles.” Annals of Occupational Hygiene 59(6): 669–680. doi:10.1093/annhyg/mev015.
   PubMedGoogle Scholar
• Rodrigues, T. C., M. L. S. Oliveira, A. Soares-Schanoski, S. L. Chavez-Rico, D. B. Figueiredo, V. M. Goncalves, D. M. Ferreira, N. K. Kunda, I. Y. Saleem, and E. N. Miyaji. 2018. “Mucosal Immunization with PspA (Pneumococcal Surface Protein a)-Adsorbed Nanoparticles Targeting the Lungs for Protection against Pneumococcal Infection.” PLOS One 13(1): e0191692. doi:10.1371/journal.pone.0191692.
   PubMed Web of Science ®Google Scholar
• Roiter, Y., M. Ornatska, A. R. Rammohan, J. Balakrishnan, D. R. Heine, and S. Minko. 2009. “Interaction of Lipid Membrane with Nanostructured Surfaces.” Langmuir 25(11): 6287–6299. doi:10.1021/la900119a.
   PubMed Web of Science ®Google Scholar
• Rothen-Rutishauser, B., J. Bourquin, and A. Petri-Fink. 2019. “Nanoparticle-Cell Interactions: Overview of Uptake, Intracellular Fate and Induction of Cell Responses.” In NanoScience and Technology - Biological Responses to Nanoscale Particles, edited by P. Gehr and R. Zellner, 153–170. Cham: Springer.
   Google Scholar
• Rudolph, C., U. Schillinger, A. Ortiz, C. Plank, M. M. Golas, B. Sander, H. Stark, and J. Rosenecker. 2005. “Aerosolized Nanogram Quantities of Plasmid DNA Mediate Highly Efficient Gene Delivery to Mouse Airway Epithelium.” Molecular Therapy 12(3): 493–501. doi:10.1016/j.ymthe.2005.03.002.
   PubMed Web of Science ®Google Scholar
• Ruge, C. A., U. F. Schaefer, J. Herrmann, J. Kirch, O. Cañadas, M. Echaide, J. Pérez-Gil, C. Casals, R. Müller, and C.-M. Lehr. 2012. “The Interplay of Lung Surfactant Proteins and Lipids Assimilates the Macrophage Clearance of Nanoparticles.” PLOS One 7(7): e40775. doi:10.1371/journal.pone.0040775.
   PubMed Web of Science ®Google Scholar
• Sadhukha, T., T. S. Wiedmann, and J. Panyam. 2013. “Inhalable Magnetic Nanoparticles for Targeted Hyperthermia in Lung Cancer Therapy.” Biomaterials 34(21): 5163–5171. doi:10.1016/j.biomaterials.2013.03.061.
   PubMed Web of Science ®Google Scholar
• Saifi, M. A., W. Khan, and C. Godugu. 2018. “Cytotoxicity of Nanomaterials: Using Nanotoxicology to Address the Safety Concerns of Nanoparticles.” Pharmaceutical Nanotechnology 6(1): 3–16. doi:10.2174/2211738505666171023152928.
   PubMedGoogle Scholar
• Sainz, V., J. Conniot, A. I. Matos, C. Peres, E. Zupanǒiǒ, L. Moura, L. C. Silva, H. F. Florindo, and R. S. Gaspar. 2015. “Regulatory Aspects on Nanomedicines.” Biochemical and Biophysical Research Communications 468(3): 504–510. doi:10.1016/j.bbrc.2015.08.023.
   PubMed Web of Science ®Google Scholar
• Salnikov, V., Y. O. Lukyanenko, C. A. Frederick, W. J. Lederer, and V. Lukyanenko. 2007. “Probing the Outer Mitochondrial Membrane in Cardiac Mitochondria with Nanoparticles.” Biophysical Journal 92(3): 1058–1071. doi:10.1529/biophysj.106.094318.
   PubMed Web of Science ®Google Scholar
• Samaridou, E., and M. J. Alonso. 2018. “Nose-to-Brain Peptide delivery - The Potential of Nanotechnology.” Bioorganic and Medicinal Chemistry 26(10): 2888–2905. doi:10.1016/j.bmc.2017.11.001.
   PubMed Web of Science ®Google Scholar
• Sangtani, A., E. Petryayeva, M. Wu, K. Susumu, E. Oh, A. L. Huston, G. Lasarte-Aragones, I. L. Medintz, W. R. Algar, and J. B. Delehanty. 2018. “Intracellularly Actuated Quantum Dot–Peptide–Doxorubicin Nanobioconjugates for Controlled Drug Delivery via the Endocytic Pathway.” Bioconjugate Chemistry 29(1): 136–148. doi:10.1021/acs.bioconjchem.7b00658.
   PubMed Web of Science ®Google Scholar
• Savage, D. T., J. Z. Hilt, and T. D. Dziubla. 2019. “In Vitro Methods for Assessing Nanoparticle Toxicity.” Methods in Molecular Biology 1894: 1–29.
   PubMedGoogle Scholar
• Sayes, C. M., A. M. Gobin, K. D. Ausman, J. Mendez, J. L. West, and V. L. Colvin. 2005. “Nano-C60 Cytotoxicity Is Due to Lipid Peroxidation.” Biomaterials 26(36): 7587–7595. doi:10.1016/j.biomaterials.2005.05.027.
   PubMed Web of Science ®Google Scholar
• Sayes, C. M., and D. B. Warheit. 2009. “Characterization of Nanomaterials for Toxicity Assessment.” Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 1(6): 660–670. doi:10.1002/wnan.58.
   PubMed Web of Science ®Google Scholar
• Schaeublin, N.M., L.K. Braydich-Stolle, A.M. Schrand, J.M. Miller, J. Hutchison, J.J. Schlager, and S.M. Hussain. 2011. “Surface Charge of Gold Nanoparticles Mediates Mechanism of Toxicity.” Nanoscale 3(2): 410–420. doi:10.1039/c0nr00478b.
   PubMed Web of Science ®Google Scholar
• Scherließ, R., and C. Etschmann. 2018. “DPI Formulations for High Dose applications – Challenges and Opportunities.” International Journal of Pharmaceutics 548(1): 49–53. doi:10.1016/j.ijpharm.2018.06.038.
   PubMed Web of Science ®Google Scholar
• Schins, R. P., R. Duffin, D. Hohr, A. M. Knaapen, T. Shi, C. Weishaupt, V. Stone, K. Donaldson, and P. J. Borm. 2002. “Surface Modification of Quartz Inhibits Toxicity, Particle Uptake, and Oxidative DNA Damage in Human Lung Epithelial Cells.” Chemical Research in Toxicology 15(9): 1166–1173. doi:10.1021/tx025558u.
   PubMed Web of Science ®Google Scholar
• Schneider, C. S., Q. Xu, N. J. Boylan, J. Chisholm, B. C. Tang, B. S. Schuster, A. Henning, et al. 2017. “Nanoparticles That Do Not Adhere to Mucus Provide Uniform and Long-Lasting Drug Delivery to Airways following Inhalation.” Science Advances 3(4): e1601556. doi:10.1126/sciadv.1601556.
   PubMed Web of Science ®Google Scholar
• Scott, C. C., F. Vacca, and J. Gruenberg. 2014. “Endosome Maturation, Transport and Functions.” Seminars in Cell and Developmental Biology 31: 2–10. doi:10.1016/j.semcdb.2014.03.034.
   PubMed Web of Science ®Google Scholar
• Seiffert, J., F. Hussain, C. Wiegman, F. Li, L. Bey, W. Baker, A. Porter, M. P. Ryan, Y. Chang, A. Gow., et al. 2015. “Pulmonary Toxicity of Instilled Silver Nanoparticles: Influence of Size, Coating and Rat Strain.” PLOS One 10(3): e0119726. doi:10.1371/journal.pone.0119726.
   PubMed Web of Science ®Google Scholar
• Sharma, B., C. B. Mcleland, T. M. Potter, S. T. Stern, and P. P. Adiseshaiah. 2018. Assessing NLRP3 Inflammasome Activation by Nanoparticles. New York, NY: Humana Press.
   Google Scholar
• Shi, X., A. Von Dem Bussche, R. H. Hurt, A. B. Kane, and H. Gao. 2011. “Cell Entry of One-Dimensional Nanomaterials Occurs by Tip Recognition and Rotation.” Nature Nanotechnology 6(11): 714–719. doi:10.1038/nnano.2011.151.
   PubMed Web of Science ®Google Scholar
• Shin, S. W., I. H. Song, and S. H. Um. 2015. “Role of Physicochemical Properties in Nanoparticle Toxicity.” Nanomaterials 5(3): 1351–1365. doi:10.3390/nano5031351.
   Web of Science ®Google Scholar
• Shirasuna, K., T. Karasawa, and M. Takahashi. 2019. “Exogenous Nanoparticles and Endogenous Crystalline Molecules as Danger Signals for the NLRP3 Inflammasomes.” Journal of Cellular Physiology 234(5): 5436–5450. doi:10.1002/jcp.27475.
   PubMed Web of Science ®Google Scholar
• Siegrist, S., E. Cörek, P. Detampel, J. Sandström, P. Wick, and J. Huwyler. 2018. “Preclinical Hazard Evaluation Strategy for Nanomedicines.” Nanotoxicology : 1–27. doi:10.1080/17435390.2018.1505000.
   PubMed Web of Science ®Google Scholar
• Silva, R. M., D. S. Anderson, L. M. Franzi, J. L. Peake, P. C. Edwards, L. S. Van Winkle, and K. E. Pinkerton. 2015. “Pulmonary Effects of Silver Nanoparticle Size, Coating, and Dose over Time upon Intratracheal Instillation.” Toxicological Sciences 144(1): 151–162. doi:10.1093/toxsci/kfu265.
   PubMed Web of Science ®Google Scholar
• Singh, N., B. C. Nelson, L. D. Scanlan, E. Coskun, P. Jaruga, and S. Doak. 2017. “Exposure to Engineered Nanomaterials: Impact on DNA Repair Pathways.” International Journal of Molecular Sciences 18(7): 1515. doi:10.3390/ijms18071515.
   Web of Science ®Google Scholar
• Slowing, I., C. W. Wu, J. L. Vivero-Escoto, and V. S. Lin. 2009. “Mesoporous Silica Nanoparticles for Reducing Hemolytic Activity towards Mammalian Red Blood Cells.” Small 5(1): 57–62. doi:10.1002/smll.200800926.
   PubMed Web of Science ®Google Scholar
• Smallshaw, J. E., J. A. Richardson, and E. S. Vitetta. 2007. “RiVax, a Recombinant Ricin Subunit Vaccine, Protects Mice against Ricin Delivered by Gavage or Aerosol.” Vaccine 25(42): 7459–7469. doi:10.1016/j.vaccine.2007.08.018.
   PubMed Web of Science ®Google Scholar
• Stein, S. W., and C. G. Thiel. 2017. “The History of Therapeutic Aerosols: A Chronological Review.” Journal of Aerosol Medicine and Pulmonary Drug Delivery 30(1): 20–41. doi:10.1089/jamp.2016.1297.
   PubMed Web of Science ®Google Scholar
• Steinhäuser, K. G., and P. G. Sayre. 2017. “Reliability of Methods and Data for Regulatory Assessment of Nanomaterial Risks.” NanoImpact 7: 66–74. doi:10.1016/j.impact.2017.06.001.
   Web of Science ®Google Scholar
• Stocks, J., and A. Hislop. 2002. “Structure and Function of the Respiratory System; Developmental Aspects and Their Relevance to Aerosol Therapy.” In Drug delivery to the lungs, edited by O. C. Bisgaard, H. Smaldone, 47–89. New York: Marcel Dekker: Inc.
   Google Scholar
• Sung, J. C., B. L. Pulliam, and D. A. Edwards. 2007. “Nanoparticles for Drug Delivery to the Lungs.” Trends in Biotechnology 25(12): 563–570. doi:10.1016/j.tibtech.2007.09.005.
   PubMed Web of Science ®Google Scholar
• Suzuki, H., K. Ueno, T. Mizumoto, Y. Seto, H. Sato, and S. Onoue. 2017. “Self-Micellizing Solid Dispersion of Cyclosporine a for Pulmonary Delivery: Physicochemical, Pharmacokinetic and Safety Assessments.” European Journal of Pharmaceutical Sciences 96: 107–114. doi:10.1016/j.ejps.2016.09.015.
   PubMed Web of Science ®Google Scholar
• Takenaka, S., E. Karg, C. Roth, H. Schulz, A. Ziesenis, U. Heinzmann, P. Schramel, and J. Heyder. 2001. “Pulmonary and Systemic Distribution of Inhaled Ultrafine Silver Particles in Rats.” Environmental Health Perspectives 109(Suppl 4): 547–551. doi:10.1289/ehp.01109s4547.
   PubMed Web of Science ®Google Scholar
• Tan, Y. F., L. L. Lao, G. M. Xiong, and S. Venkatraman. 2018. “Controlled-Release Nanotherapeutics: State of Translation.” Journal of Controlled Release 284: 39–48. doi:10.1016/j.jconrel.2018.06.014.
   PubMed Web of Science ®Google Scholar
• Tang, D., R. Kang, T. V. Berghe, P. Vandenabeele, and G. Kroemer. 2019. “The Molecular Machinery of Regulated Cell Death.” Cell Research 29(5): 347–364. doi:10.1038/s41422-019-0164-5.
   PubMed Web of Science ®Google Scholar
• Tarantola, M., D. Schneider, E. Sunnick, H. Adam, S. Pierrat, C. Rosman, V. Breus, et al. 2009. “Cytotoxicity of Metal and Semiconductor Nanoparticles Indicated by Cellular Micromotility.” ACS Nano 3(1): 213–222. doi:10.1021/nn800721j.
   PubMed Web of Science ®Google Scholar
• Taratula, O., O. B. Garbuzenko, A. M. Chen, and T. Minko. 2011. “Innovative Strategy for Treatment of Lung Cancer: Targeted Nanotechnology-Based Inhalation co-Delivery of Anticancer Drugs and siRNA.” Journal of Drug Targeting 19(10): 900–914. doi:10.3109/1061186X.2011.622404.
   PubMed Web of Science ®Google Scholar
• Tawfeek, H. M., A. R. Evans, A. Iftikhar, A. R. Mohammed, A. Shabir, S. Somavarapu, G. A. Hutcheon, and I. Y. Saleem. 2013. “Dry Powder Inhalation of Macromolecules Using Novel PEG-co-Polyester Microparticle Carriers.” International Journal of Pharmaceutics 441(1-2): 611–619. doi:10.1016/j.ijpharm.2012.10.036.
   PubMed Web of Science ®Google Scholar
• Truong, N. P., M. R. Whittaker, C. W. Mak, and T. P. Davis. 2015. “The Importance of Nanoparticle Shape in Cancer Drug Delivery.” Expert Opinion on Drug Delivery 12(1): 129–142. doi:10.1517/17425247.2014.950564.
   PubMed Web of Science ®Google Scholar
• Tsapis, N., D. Bennett, B. Jackson, D. A. Weitz, and D. A. Edwards. 2002. “Trojan Particles: Large Porous Carriers of Nanoparticles for Drug Delivery.” Proceedings of the National Academy of Sciences 99(19): 12001–12005. doi:10.1073/pnas.182233999.
   PubMed Web of Science ®Google Scholar
• Tseng, C. L., W. Y. Su, K. C. Yen, K. C. Yang, and F. H. Lin. 2009. “The Use of biotinylated-EGF-Modified Gelatin Nanoparticle Carrier to Enhance Cisplatin Accumulation in Cancerous Lungs via Inhalation.” Biomaterials 30(20): 3476–3485. doi:10.1016/j.biomaterials.2009.03.010.
   PubMed Web of Science ®Google Scholar
• Upadhyay, S., and L. Palmberg. 2018. “Air-Liquid Interface: Relevant in Vitro Models for Investigating Air Pollutant-Induced Pulmonary Toxicity.” Toxicological Sciences 164(1): 21–30. doi:10.1093/toxsci/kfy053.
   PubMed Web of Science ®Google Scholar
• Vallabani, N. V. S., S. Singh, and A. Karakoti. 2019. “Magnetic Nanoparticles: Current Trends and Future Aspects in Diagnostics and Nanomedicine.” Current Drug Metabolism 20(6): 457. doi:10.2174/1389200220666181122124458.
   PubMed Web of Science ®Google Scholar
• Verma, N. K., K. Crosbie-Staunton, A. Satti, S. Gallagher, K. B. Ryan, T. Doody, C. Mcatamney, et al. 2013. “Magnetic Core-Shell Nanoparticles for Drug Delivery by Nebulization.” Journal of Nanobiotechnology 11(1): 1. doi:10.1186/1477-3155-11-1.
   PubMedGoogle Scholar
• Verschraegen, C. F., B. E. Gilbert, E. Loyer, A. Huaringa, G. Walsh, R. A. Newman, and V. Knight. 2004. “Clinical Evaluation of the Delivery and Safety of Aerosolized Liposomal 9-Nitro-20(s)-Camptothecin in Patients with Advanced Pulmonary Malignancies.” Clinical Cancer Research 10(7): 2319–2326. doi:10.1158/1078-0432.CCR-0929-3.
   PubMed Web of Science ®Google Scholar
• Vij, N., T. Min, R. Marasigan, C. N. Belcher, S. Mazur, H. Ding, K. T. Yong, and I. Roy. 2010. “Development of PEGylated PLGA Nanoparticle for Controlled and Sustained Drug Delivery in Cystic Fibrosis.” Journal of Nanobiotechnology 8: 22. doi:10.1186/1477-3155-8-22.
   PubMedGoogle Scholar
• Vilanova, O., J. J. Mittag, P. M. Kelly, S. Milani, K. A. Dawson, J. O. Radler, and G. Franzese. 2016. “Understanding the Kinetics of Protein-Nanoparticle Corona Formation.” ACS Nano 10, 10842–10850. doi:10.1021/acsnano.6b04858.
   PubMed Web of Science ®Google Scholar
• Vilar, G., J. Tulla-Puche, and F. Albericio. 2012. “Polymers and Drug Delivery Systems.” Current Drug Delivery 9(4): 367–394.
   PubMed Web of Science ®Google Scholar
• Wagner, A. M., M. P. Gran, and N. A. Peppas. 2018. “Designing the New Generation of Intelligent Biocompatible Carriers for Protein and Peptide Delivery.” Acta Pharmaceutica Sinica B 8(2): 147. doi:10.1016/j.apsb.2018.01.013.
   PubMed Web of Science ®Google Scholar
• Wang, T., J. Bai, X. Jiang, and G. U. Nienhaus. 2012. “Cellular Uptake of Nanoparticles by Membrane Penetration: A Study Combining Confocal Microscopy with FTIR Spectroelectrochemistry.” ACS Nano 6(2): 1251–1259. doi:10.1021/nn203892h.
   PubMed Web of Science ®Google Scholar
• Wang, Y., M. Beck-Broichsitter, M. Yang, J. Rantanen, and A. Bohr. 2017. “Investigation of Nanocarriers and Excipients for Preparation of Nanoembedded Microparticles.” International Journal of Pharmaceutics 526(1–2): 300–308. doi:10.1016/j.ijpharm.2017.05.008.
   PubMed Web of Science ®Google Scholar
• Wang, Y., J. Y. Li, A. Leavey, C. O'neil, H. M. Babcock, and P. Biswas. 2017. “Comparative Study on the Size Distributions, Respiratory Deposition, and Transport of Particles Generated from Commonly Used Medical Nebulizers.” Journal of Aerosol Medicine and Pulmonary Drug Delivery 30(2): 132–140. doi:10.1089/jamp.2016.1340.
   PubMed Web of Science ®Google Scholar
• Wang, J., W. Mao, L. L. Lock, J. Tang, M. Sui, W. Sun, H. Cui, D. Xu, and Y. Shen. 2015. “The Role of Micelle Size in Tumor Accumulation, Penetration, and Treatment.” ACS Nano 9(7): 7195–7206. doi:10.1021/acsnano.5b02017.
   PubMed Web of Science ®Google Scholar
• Wang, Y., H. Zhang, J. Hao, B. Li, M. Li, and W. Xiuwen. 2016. “Lung Cancer Combination Therapy: Co-Delivery of Paclitaxel and Doxorubicin by Nanostructured Lipid Carriers for Synergistic Effect.” Drug Delivery 23: 1398–1403. doi:10.3109/10717544.2015.1055619.
   PubMed Web of Science ®Google Scholar
• Warheit, D. 2018. “Hazard and risk assessment strategies for nanoparticle exposures: How far have we come in the past 10 years?” F1000Research 7: 376. doi:10.12688/f1000research.12691.1.
   PubMedGoogle Scholar
• WHO. 2018. “The top 10 causes of Death [online].” World Health Organization. http://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed 2018.
   Google Scholar
• Wick, P., S. Chortarea, T. Guenat Olivier, M. Roesslein, D. Stucki Janick, S. Hirn, A. Petri-Fink, and B. Rothen-Rutishauser. 2015. “In Vitro-Ex Vivo Model Systems for Nanosafety Assessment.” European Journal of Nanomedicine 169. doi:10.1515/ejnm-2014-0049.
   Google Scholar
• Wiemann, M., A. Vennemann, F. Blaske, M. Sperling, and U. Karst. 2017. “Silver Nanoparticles in the Lung: Toxic Effects and Focal Accumulation of Silver in Remote Organs.” Nanomaterials 7(12): 441. doi:10.3390/nano7120441.
   Web of Science ®Google Scholar
• Wittgen, B. P., P. W. Kunst, K. Van Der Born, A. W. Van Wijk, W. Perkins, F. G. Pilkiewicz, R. Perez-Soler, S. Nicholson, G. J. Peters, and P. E. Postmus. 2007. “Phase I Study of Aerosolized SLIT Cisplatin in the Treatment of Patients with Carcinoma of the lung.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 13(8): 2414–2421. doi:10.1158/1078-0432.CCR-06-1480.
   PubMed Web of Science ®Google Scholar
• Wu, L., J. Zhang, and W. Watanabe. 2011. “Physical and Chemical Stability of Drug Nanoparticles.” Advanced Drug Delivery Reviews 63(6): 456–469. doi:10.1016/j.addr.2011.02.001.
   PubMed Web of Science ®Google Scholar
• Xia, T., M. Kovochich, J. Brant, M. Hotze, J. Sempf, T. Oberley, C. Sioutas, J. I. Yeh, M. R. Wiesner, and A. E. Nel. 2006. “Comparison of the Abilities of Ambient and Manufactured Nanoparticles to Induce Cellular Toxicity according to an Oxidative Stress Paradigm.” Nano Letters 6(8): 1794–1807. doi:10.1021/nl061025k.
   PubMed Web of Science ®Google Scholar
• Xia, T., M. Kovochich, M. Liong, L. Madler, B. Gilbert, H. Shi, J. I. Yeh, J. I. Zink, and A. E. Nel. 2008. “Comparison of the Mechanism of Toxicity of Zinc Oxide and Cerium Oxide Nanoparticles Based on Dissolution and Oxidative Stress Properties.” ACS Nano 2(10): 2121–2134. doi:10.1021/nn800511k.
   PubMed Web of Science ®Google Scholar
• Xia, T., Y. Zhu, L. Mu, Z. F. Zhang, and S. Liu. 2016. “Pulmonary Diseases Induced by Ambient Ultrafine and Engineered Nanoparticles in Twenty-First Century.” National Science Review 3(4): 416–429.
   PubMed Web of Science ®Google Scholar
• Yan, G., A. Li, A. Zhang, Y. Sun, and J. Liu. 2018. “Polymer-Based Nanocarriers for Co-Delivery and Combination of Diverse Therapies against Cancers.” Nanomaterials 8(2): 85. doi:10.3390/nano8020085.
   Web of Science ®Google Scholar
• Yan, Y., K. Zhou, H. Xiong, J. B. Miller, E. A. Motea, D. A. Boothman, L. Liu, and D. J. Siegwart. 2017. “Aerosol Delivery of Stabilized Polyester-siRNA Nanoparticles to Silence Gene Expression in Orthotopic Lung Tumors.” Biomaterials 118: 84–93. doi:10.1016/j.biomaterials.2016.12.001.
   PubMed Web of Science ®Google Scholar
• Yeh, Y. C., K. Saha, B. Yan, O. R. Miranda, X. Yu, and V. M. Rotello. 2013. “The Role of Ligand Coordination on the Cytotoxicity of Cationic Quantum Dots in HeLa Cells.” Nanoscale 5(24): 12140–12143. doi:10.1039/c3nr04037b.
   PubMed Web of Science ®Google Scholar
• Zamboni, W. C., V. Torchilin, A. K. Patri, J. Hrkach, S. Stern, R. Lee, A. Nel, N. J. Panaro, and P. Grodzinski. 2012. “Best Practices in Cancer Nanotechnology: Perspective from NCI Nanotechnology Alliance.” Clinical Cancer Research 18(12): 3229–3241. doi:10.1158/1078-0432.CCR-11-2938.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., Y.-R. Leu, R. J. Aitken, and M. Riediker. 2015. “Inventory of Engineered Nanoparticle-Containing Consumer Products Available in the Singapore Retail Market and Likelihood of Release into the Aquatic Environment.” International Journal of Environmental Research and Public Health 12(8): 8717–8743. doi:10.3390/ijerph120808717.
   PubMed Web of Science ®Google Scholar
• Zhang, M., E. Liu, Y. Cui, and Y. Huang. 2017. “Nanotechnology-Based Combination Therapy for Overcoming Multidrug-Resistant Cancer.” Cancer Biology and Medicine 14: 212–227. doi:10.20892/j.issn.2095-3941.2017.0054.
   PubMed Web of Science ®Google Scholar
• Zhao, X., S. Ng, B. C. Heng, J. Guo, L. Ma, T. T. Tan, K. W. Ng, and S. C. Loo. 2013. “Cytotoxicity of Hydroxyapatite Nanoparticles Is Shape and Cell Dependent.” Archives of Toxicology 87(6): 1037–1052. doi:10.1007/s00204-012-0827-1.
   PubMed Web of Science ®Google Scholar
• Zhao, Z., A. Ukidve, V. Krishnan, and S. Mitragotri. 2019. “Effect of Physicochemical and Surface Properties on in Vivo Fate of Drug Nanocarriers.” Advanced Drug Delivery Review. doi:10.1016/j.addr.2019.01.002
   Web of Science ®Google Scholar
• Zhou, L., H. Wang, and Y. Li. 2018. “Stimuli-Responsive Nanomedicines for Overcoming Cancer Multidrug Resistance.” Theranostics 8(4): 1059–1074. doi:10.7150/thno.22679.
   PubMed Web of Science ®Google Scholar
• Zimmer, A. 2002. “Drug Targeting Technology, Physical⋅Chemical⋅Biological Methods, Edited by Hans Schreier.” ChemBioChem 3(6): 581–581. doi:10.1002/1439-7633(20020603)3:6<581::AID-CBIC581>3.0.CO;2-J.
   Google Scholar
• Zinchenko, A. A., F. Luckel, and K. Yoshikawa. 2007. “Transcription of Giant DNA Complexed with Cationic Nanoparticles as a Simple Model of Chromatin.” Biophysical Journal 92(4): 1318–1325. doi:10.1529/biophysj.106.094185.
   PubMed Web of Science ®Google Scholar